ReNEW is a global research study evaluating an investigational therapy in subjects with dry age-related macular degeneration (Dry AMD).

Dry AMD is a leading cause of blindness impacting more than five million people worldwide, which can severely impair visual function, independence, and quality of life. Dry AMD is a progressive retinal disease involving photoreceptors, which are specialized neurons found in the retina that convert light into electrical signals. Their function is required for normal vision. In dry AMD, photoreceptors suffer progressive damage and death, leading to progressive loss of vision.